Siemens AG ADR Stock
Siemens AG ADR Stock
The Siemens AG ADR price is unchanged compared to yesterday.
So far the community has only identified positive things for Siemens AG ADR stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Siemens AG ADR in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Siemens AG ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Siemens AG ADR | 0.000% | -2.113% | 2.963% | 23.009% | 19.828% | 104.412% | 95.775% |
| Wartsila B | -0.070% | 1.947% | -1.355% | 23.245% | -1.712% | 164.042% | 134.947% |
| Siam Cement Pcl Fgn | 0.000% | -1.481% | 4.724% | 26.667% | 29.126% | -16.875% | -37.264% |
| Hitachi Ltd Adr/10 | 0.000% | -3.226% | 21.951% | 23.967% | 15.385% | -73.913% | -68.750% |
Comments
Shoulder Innovations (SI) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for SI provided by MarketBeat
Shoulder Innovations (SI) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $25.00 price target on the stock, up from $19.00.
Show more
Ratings data for SI provided by MarketBeat
Shoulder Innovations (SI) had its price target raised by BTIG Research from $24.00 to $26.00. They now have a "buy" rating on the stock.
Show more
Ratings data for SI provided by MarketBeat
News
GE Vernova’s AI Power Boom Faces a Profit Test
Key Points
- Interested in GE Vernova Inc.? Here are five stocks we like better.
- GE Vernova posted 22% revenue growth and a record $176 billion backlog in the second quarter of 2026, but adjusted
Babcock Q2 Earnings Call Highlights
Key Points
- Interested in Babcock? Here are five stocks we like better.
- Second-quarter results surpassed expectations: Revenue rose 130% year over year to $319.7 million, while net income
Profound Medical Q2 Earnings Call Highlights
Key Points
- Interested in Profound Medical? Here are five stocks we like better.
- Q2 revenue rose 12% to CAD 2.5 million, but about CAD 3.1 million in TULSA shipments moved from June into July